These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16438629)
21. [Aggressive chronic hepatitis during methyldopa therapy]. Balázs M; Kovách G Orv Hetil; 1980 Mar; 121(12):705-7. PubMed ID: 7383647 [No Abstract] [Full Text] [Related]
22. Methyldopa-induced granulomatous hepatitis. Mirada Canals A; Monteagudo Jimenez M; Sole Villa J; Rodriguez Moreno C DICP; 1991 Nov; 25(11):1269-70. PubMed ID: 1763547 [No Abstract] [Full Text] [Related]
23. [New forms of toxic hepatitis. II]. Markoff N Hippokrates; 1973 Dec; 44(4):454-5. PubMed ID: 4779551 [No Abstract] [Full Text] [Related]
24. Chronic hepatitis and indolent cirrhosis due to methyldopa: the bottom of the iceberg? Lee WM; Denton WT J S C Med Assoc; 1989 Feb; 85(2):75-9. PubMed ID: 2918709 [No Abstract] [Full Text] [Related]
25. [Methyldopa-induced hepatitis: 3 case reports]. Daghfous R; el Aidli S; Loueslati MH; Sakka T; Lakhal M; Ben Mami N; Ben Khelifa H; Belkahia CH Tunis Med; 1994 Jan; 72(1):47-50. PubMed ID: 8203031 [No Abstract] [Full Text] [Related]
26. Hepatitis and hemolytic anemia associated with methyldopa therapy. Breland BD; Hicks GS Drug Intell Clin Pharm; 1982 Jun; 16(6):489-92. PubMed ID: 7094845 [TBL] [Abstract][Full Text] [Related]
28. [Fatal toxic hepatitis in pregnancy. A discussion of the role of methyldopa]. Picaud A; Walter P; de Préville G; Nicolas P J Gynecol Obstet Biol Reprod (Paris); 1990; 19(2):192-6. PubMed ID: 2324442 [TBL] [Abstract][Full Text] [Related]
30. Fulminant hepatic failure associated with methyldopa. Puppala AR; Steinheber FU Am J Gastroenterol; 1977 Dec; 68(6):578-81. PubMed ID: 77129 [TBL] [Abstract][Full Text] [Related]
31. [Chronic hepatitis with elevated level of endoplasmic anti-reticulum antibodies: alpha-methyldopa or tienilic acid?]. Beaugrand M; Gavillon C; Ferrier JP Gastroenterol Clin Biol; 1981; 5(8-9):819-20. PubMed ID: 7297821 [No Abstract] [Full Text] [Related]
32. Liver disease caused by medicinal agents. Zimmerman HJ Med Clin North Am; 1975 Jul; 59(4):897-907. PubMed ID: 1142866 [No Abstract] [Full Text] [Related]
33. Severe liver toxicity after methyldopa. Zarday Z; Rosenthal WS; Wolff FW N Y State J Med; 1967 Jul; 67(13):1897-9. PubMed ID: 5232672 [No Abstract] [Full Text] [Related]
34. Hepatitis, arthritis and lupus cell phenomena caused by methyldopa. Eliastam M; Holmes AW Am J Dig Dis; 1971 Nov; 16(11):1014-8. PubMed ID: 4108488 [No Abstract] [Full Text] [Related]
35. [High levels of endoplasmic reticulum antibody titer in a case of alpha-methyldopa-induced chronic active hepatitis (author's transl)]. Beaugrand M; Gavillon C; Ferrier JP Gastroenterol Clin Biol; 1980 Mar; 4(3):219-21. PubMed ID: 7380145 [No Abstract] [Full Text] [Related]
36. Methyldopa Hepatitis. A report of six cases and review of the literature. Rodman JS; Deutsch DJ; Gutman SI Am J Med; 1976 Jun; 60(7):941-8. PubMed ID: 937354 [TBL] [Abstract][Full Text] [Related]
37. Proceedings: Liver damage in patients taking methyldopa. Toghill PJ; Smith PG; Benton P; Brown RC; Matthews HL Gut; 1974 Apr; 15(4):342-3. PubMed ID: 4834576 [No Abstract] [Full Text] [Related]
38. Methyldopa hepatitis. Report of three cases. Hoyumpa AM; Connell AM Am J Dig Dis; 1973 Mar; 18(3):213-22. PubMed ID: 4688573 [No Abstract] [Full Text] [Related]
39. Drug-induced chronic liver disease, with emphasis on chronic active hepatitis. Seeff LB Semin Liver Dis; 1981 May; 1(2):104-15. PubMed ID: 7051296 [No Abstract] [Full Text] [Related]
40. [Hepatic injury caused by methyldopa in a pre-eclamptic patient]. Minakami H; Ohkusa T; Kimura K; Tamada T; Hirota N Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):139-42. PubMed ID: 3950462 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]